Lupin Ltd
Ticker: LUPIN
Decent
75/100
☆ Add to Watchlist
Investing Reference
Price
1940.50
Market Cap
88633.86
Debt/Equity
0.3150
ROE %
20.725
PB
5.1250
Promoter %
46.902
Pledge %
0.000
1Y Rev Growth %
13.743
5Y Rev Growth %
7.453
NP Margin %
14.324
NP Margin 5Y Avg %
5.029
Trading Reference
1M Return %
-5.095
6M Return %
-3.592
1Y Return %
-13.790
% Away 52W High
23.829
% Away 52W Low
8.094
Daily Volume
636814
Investment Verdict
Risky
Score 53/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 19/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Lupin Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, it could see an upside potential of approximately 15%. However, if it falls below the support level, there is a downside risk of around 10%.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Bajaj Housing Finance Ltd
Bajaj Housing Finance Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks.
View details
G
GMR Airports Ltd
GMR Airports Ltd shows potential for growth in a recovering sector, but faces challenges in profitability and valuation metrics.
View details
J
JSW Energy Ltd
JSW Energy Ltd shows potential for growth in the renewable energy sector, but investors should be cautious of cash flow issues and governance concerns.
View details
B
BSE Ltd
BSE Ltd shows potential for growth but faces challenges in profitability and execution risks. Investors should be cautious.
View details
H
Hitachi Energy India Ltd
Hitachi Energy India Ltd shows a decent investment potential with solid growth prospects in a future-ready sector, though valuation concerns and execution risks should be monitored.
View details
I
Info Edge (India) Ltd
Info Edge (India) Ltd shows decent potential with strong growth and profitability metrics, but valuation concerns and execution risks should be monitored.
View details
S
SRF Ltd
SRF Ltd shows potential for growth in a favorable sector, but investors should be cautious of valuation and execution risks.
View details
N
Ntpc Green Energy Ltd
Ntpc Green Energy Ltd shows potential in the renewable sector, but faces challenges in profitability and execution risks.
View details
I
ICICI Prudential Life Insurance Company Ltd
ICICI Prudential Life Insurance has a decent outlook with growth potential, but investors should be cautious of valuation and execution risks.
View details
B
Bharti Hexacom Ltd
Bharti Hexacom Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
H
Hindustan Petroleum Corp Ltd
Hindustan Petroleum Corp Ltd shows potential for growth but faces significant risks and challenges in profitability and market valuation.
View details
P
Persistent Systems Ltd
Persistent Systems Ltd shows potential for growth but faces challenges in profitability and valuation metrics. It is advisable to monitor closely before making investment decisions.
View details
N
NHPC Ltd
NHPC Ltd shows decent potential with growth opportunities in the renewable sector, but faces challenges in profitability and valuation metrics.
View details
V
Vodafone Idea Ltd
Vodafone Idea Ltd faces significant challenges in growth, profitability, and financial stability, making it a risky investment.
View details
P
PB Fintech Ltd
PB Fintech Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
S
SBI Cards and Payment Services Ltd
SBI Cards shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Lupin Ltd is a prominent Indian pharmaceutical company known for its commitment to innovation and quality. With a diverse portfolio that includes generics, branded formulations, and biotechnology, Lupin caters to a global market, ensuring access to essential medicines. The company focuses on research and development, driving advancements in healthcare. Its strong presence in both domestic and international markets makes it a reliable choice for investors looking for stability and growth in the pharmaceutical sector.
- Established leader in the pharmaceutical industry
- Wide range of products catering to global health needs
- Strong focus on research and innovation
- Robust financial performance and growth potential
- Commitment to quality and compliance
- Expanding presence in emerging markets
Investment Thesis
Lupin Ltd stands out as a compelling investment opportunity due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and profitability in the evolving pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services expands market reach and revenue streams.
- Attractive valuation metrics provide a favorable entry point for investors.
- Robust pipeline of products supports long-term growth prospects.
- Strategic focus on innovation positions Lupin to capitalize on emerging market trends.
Opportunity vs Risk
Opportunities
- Strong pipeline of new drugs
- Expanding international markets
- Increasing demand for generics
- Strategic acquisitions potential
- Focus on R&D innovation
Risks ⚠️
- Regulatory hurdles in key markets
- Intense competition in generics
- Currency fluctuation impacts
- Rising raw material costs
- Dependence on US market sales
Peer Perspective
Lupin Ltd trades at a discount to peers like Dr. Reddy's and Sun Pharma, primarily due to margin pressures. A stable margin outlook and growth acceleration could trigger a rerating in its valuation.
Future Outlook
Lupin Ltd is well-positioned for growth, driven by its strong pipeline and expanding global presence; however, successful execution and stringent cost control will be crucial to navigate potential market challenges.
AI FAQs for Retail Users
- Q: What does Lupin Ltd do?A: Lupin Ltd is a global pharmaceutical company that develops and manufactures a wide range of medications.
- Q: Is Lupin Ltd a good investment?A: Investment decisions should be based on individual financial goals and market research. Consult a financial advisor.
- Q: What are the key products of Lupin Ltd?A: Lupin produces generic drugs, branded formulations, and active pharmaceutical ingredients across various therapeutic areas.
- Q: How has Lupin Ltd performed recently?A: Recent performance can be checked through financial news and stock market reports for up-to-date information.
- Q: What risks should I consider with Lupin Ltd?A: Consider market competition, regulatory changes, and global economic conditions that may impact the pharmaceutical industry.
📊 Stock Investment Checklist (100 Points)
Lupin Ltd • Updated: 2025-09-17 03:24:21
-
10BusinessHighPharmaceutical sector is essential but faces regulatory challenges.
-
10GrowthHighModerate revenue growth with some fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are decent but OCF has been inconsistent.
-
10ValuationHighP/E and P/B ratios are in line with industry averages.
-
8BalanceHighManageable debt levels but liquidity could be improved.
-
7GovernanceHighPromoter holding is stable, but some pledging exists.
-
8DriversHighStrong pipeline of products but execution risks remain.
-
5TechnicalsGoodMarket sentiment is mixed with low liquidity.
Final Score & Verdict
Score 75 / 100
• Decent
Lupin Ltd shows potential for growth but faces several challenges that could impact its performance.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100